Cargando…
Immunity to SARS-CoV-2: What Do We Know and Should We Be Testing for It?
Preexisting immunity to Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) was nonexistent in humans, which coupled with high transmission rates of certain SARS-CoV-2 variants and limited vaccine uptake or availability, has collectively resulted in an ongoing global pandemic. The identific...
Autores principales: | Misra, Anisha, Theel, Elitza S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9199399/ https://www.ncbi.nlm.nih.gov/pubmed/35249377 http://dx.doi.org/10.1128/jcm.00482-21 |
Ejemplares similares
-
Cardiovascular assessment in liver transplant for non-alcoholic steatohepatitis patients: What we do, what we should do
por: Sanchez-Torrijos, Yolanda, et al.
Publicado: (2017) -
Assessing the prognosis of cirrhotic patients in the intensive care unit: What we know and what we need to know better
por: da Silveira, Fernando, et al.
Publicado: (2021) -
Multimorbidity: What do we know? What should we do?
por: Navickas, Rokas, et al.
Publicado: (2016) -
Association between acute pancreatitis and COVID-19 infection: What do we know?
por: Jabłońska, Beata, et al.
Publicado: (2021) -
What We Know Currently about Mirror Neurons
por: Kilner, J.M., et al.
Publicado: (2013)